NT_1170x120_1-11-18

CHPA conference to discuss issues affecting the industry and market

Print Friendly, PDF & Email

WASHINGTON – The Consumer Healthcare Products Association (CHPA) will hold its 2019 Regulatory, Scientific & Quality Conference (RSQ), May 21 to 22 in North Bethesda, Md. to discuss key regulatory, scientific, quality, and legal issues impacting the consumer healthcare products industry, such as incorporating new technologies, innovative ways of thinking, and regulatory developments to advance consumer self-care.

The annual, two-day event covers a range of important topics affecting the OTC marketplace with sessions comprised of panelists from the U.S. Food and Drug Administration (FDA), U.S. Pharmacopeia Convention (USP), industry, and academia. Among this year’s featured speakers are FDA officials including Lauren Silvis, chief of staff, and Rear Admiral Denise Hinton, chief scientist.

A full list of speakers and an agenda can be found here.

WHO:              Food and Drug Administration (FDA) officials, including Lauren Silvis, chief of staff, FDA and Rear Admiral Denise Hinton, chief scientist, FDA. Other FDA officials will be participating in various panels with an impressive line-up of speakers and panelists from U.S. Pharmacopeia Convention (USP), as well as industry and academic experts.

WHAT:            The Consumer Healthcare Products Association (CHPA) 2019 Regulatory, Scientific & Quality (RSQ) Conference, featuring speakers from FDA and other federal agencies along with industry and regulatory experts to discuss key issues affecting the consumer healthcare industry.

WHEN:            Tuesday, May 21 to Wednesday, May 22, 2019

WHERE:         Bethesda North Marriott Hotel
5701 Marinelli Road
North Bethesda, MD 20852


EMC_728x90

NB-OSTEO_728x90

Comments are closed.